New study reveals microdosing psychedelics could help those with ADHD

New research has found that microdosing psychedelics could help people with ADHD.

In a study made by the Department of Neuropsychology and Psychopharmacology at Maastricht University, Netherlands, new data reveals the benefits of microdosing for people with the condition.

Read this next: Are we close to the legalisation of therapeutic psychedelics?

According to the department, adults diagnosed with ADHD generally have lower levels of mindfulness with the NHS explaining that most adults with the condition have issues focusing and completing tasks, coping with stress and feeling restless or impatient.

However, the results of this new study found that over 80% of the nearly 250 participants indicated having practised mindfulness.

The study saw people repeatedly take small amounts of non-hallucinogenic psychedelics across four weeks measuring their mindfulness and personality traits throughout.

Read this next: White supremacist “loses extremist views” after taking MDMA

The results read: “Trait mindfulness, specifically description and non-judging of inner experience, was increased, and neuroticism was decreased after 4 weeks of MD compared to baseline.”

“Using conventional medication and/or having comorbid diagnoses did not change the MD-induced effects on mindfulness and personality traits after 4 weeks,” it adds.

It is estimated that there is a total of 2.6 million people in the UK with ADHD as reported by ADHD UK.

Back in 2019, PLOS One found that microdosing psychedelics can also help reduce depressive symptoms and stress whilst also boosting focus.

The results explained however that these results “highlight some important possible effects of microdosing, but more careful follow-up research is needed to confirm these findings".

Read the full study by the Department of Neuropsychology and Psychopharmacology here.

Becky Buckle is Mixmag's Multimedia Editor, follow her on Twitter